Loading…
5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors
A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2010-11, Vol.20 (22), p.6696-6698 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393 |
---|---|
cites | cdi_FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393 |
container_end_page | 6698 |
container_issue | 22 |
container_start_page | 6696 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 20 |
creator | Asano, Shigehiro Komiya, Masafumi Koike, Nobuyuki Koga, Erina Nakatani, Shogo Isobe, Yoshiaki |
description | A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8p was 25-fold higher than that of KN-93, a known CaMKII inhibitor. Michaelis–Menten analysis of a representative compound suggested that the synthesized pyrimidines are calmodulin non-competitive inhibitors. Finally, 8p exhibited more than 100-fold higher selectivity for CaMKII over five types of off-target kinases. |
doi_str_mv | 10.1016/j.bmcl.2010.09.005 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_867749891</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X10012965</els_id><sourcerecordid>759323660</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393</originalsourceid><addsrcrecordid>eNqFkU9vEzEQxS1ERdPCF-CAfEFcsul4_W8tcUERhYhWXIqEhJDltb3E0Wad2ptI-fZ4lQA3ehrN6DdvRu8h9JrAggARN5tFu7X9ooYyALUA4M_QjDDBKsqAP0czUAKqRrHvl-gq5w0AYcDYC3RZQyO5pM0MbfhczOW8qR78mMz66FLcHVNw8Qeb08r9nJptcGHwGZuMh3jwPba9yRnHDu_i6IcRm8Hhdfi17o84-97bMRw8Xpr7L6sVDsM6tGGMKb9EF53ps391rtfo2-3Hh-Xn6u7rp9Xyw11lGZFjJXkLpBat5MQYxb0hrRDS1lSYRjqQnjBmC8q7WgneGNoKThy4xlhhBVX0Gr076e5SfNz7POptyNb3vRl83GfdCCmZahR5kpRc0XJXQCHrE2lTzDn5Tu-KLyYdNQE9haE3egpDT2FoULqEUZbenOX37da7vyt_3C_A2zNgsjV9l8xgQ_7HUap4LSah9yfOF9sOwSedbfCD9S6k4rZ2Mfzvj98bjKZv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>759323660</pqid></control><display><type>article</type><title>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors</title><source>ScienceDirect Journals</source><creator>Asano, Shigehiro ; Komiya, Masafumi ; Koike, Nobuyuki ; Koga, Erina ; Nakatani, Shogo ; Isobe, Yoshiaki</creator><creatorcontrib>Asano, Shigehiro ; Komiya, Masafumi ; Koike, Nobuyuki ; Koga, Erina ; Nakatani, Shogo ; Isobe, Yoshiaki</creatorcontrib><description>A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8p was 25-fold higher than that of KN-93, a known CaMKII inhibitor. Michaelis–Menten analysis of a representative compound suggested that the synthesized pyrimidines are calmodulin non-competitive inhibitors. Finally, 8p exhibited more than 100-fold higher selectivity for CaMKII over five types of off-target kinases.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.09.005</identifier><identifier>PMID: 20875738</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines ; Analytical, structural and metabolic biochemistry ; Biological and medical sciences ; Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists & inhibitors ; Calmodulin-dependent protein kinase II ; Enzymes and enzyme inhibitors ; Fundamental and applied biological sciences. Psychology ; Inhibitors ; Medical sciences ; Miscellaneous ; Pharmacology. Drug treatments ; Protein Kinase Inhibitors - pharmacology ; Pyrimidines - pharmacology ; Transferases</subject><ispartof>Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6696-6698</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393</citedby><cites>FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23395265$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20875738$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Asano, Shigehiro</creatorcontrib><creatorcontrib>Komiya, Masafumi</creatorcontrib><creatorcontrib>Koike, Nobuyuki</creatorcontrib><creatorcontrib>Koga, Erina</creatorcontrib><creatorcontrib>Nakatani, Shogo</creatorcontrib><creatorcontrib>Isobe, Yoshiaki</creatorcontrib><title>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8p was 25-fold higher than that of KN-93, a known CaMKII inhibitor. Michaelis–Menten analysis of a representative compound suggested that the synthesized pyrimidines are calmodulin non-competitive inhibitors. Finally, 8p exhibited more than 100-fold higher selectivity for CaMKII over five types of off-target kinases.</description><subject>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines</subject><subject>Analytical, structural and metabolic biochemistry</subject><subject>Biological and medical sciences</subject><subject>Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists & inhibitors</subject><subject>Calmodulin-dependent protein kinase II</subject><subject>Enzymes and enzyme inhibitors</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Inhibitors</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Pyrimidines - pharmacology</subject><subject>Transferases</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqFkU9vEzEQxS1ERdPCF-CAfEFcsul4_W8tcUERhYhWXIqEhJDltb3E0Wad2ptI-fZ4lQA3ehrN6DdvRu8h9JrAggARN5tFu7X9ooYyALUA4M_QjDDBKsqAP0czUAKqRrHvl-gq5w0AYcDYC3RZQyO5pM0MbfhczOW8qR78mMz66FLcHVNw8Qeb08r9nJptcGHwGZuMh3jwPba9yRnHDu_i6IcRm8Hhdfi17o84-97bMRw8Xpr7L6sVDsM6tGGMKb9EF53ps391rtfo2-3Hh-Xn6u7rp9Xyw11lGZFjJXkLpBat5MQYxb0hrRDS1lSYRjqQnjBmC8q7WgneGNoKThy4xlhhBVX0Gr076e5SfNz7POptyNb3vRl83GfdCCmZahR5kpRc0XJXQCHrE2lTzDn5Tu-KLyYdNQE9haE3egpDT2FoULqEUZbenOX37da7vyt_3C_A2zNgsjV9l8xgQ_7HUap4LSah9yfOF9sOwSedbfCD9S6k4rZ2Mfzvj98bjKZv</recordid><startdate>20101115</startdate><enddate>20101115</enddate><creator>Asano, Shigehiro</creator><creator>Komiya, Masafumi</creator><creator>Koike, Nobuyuki</creator><creator>Koga, Erina</creator><creator>Nakatani, Shogo</creator><creator>Isobe, Yoshiaki</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20101115</creationdate><title>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors</title><author>Asano, Shigehiro ; Komiya, Masafumi ; Koike, Nobuyuki ; Koga, Erina ; Nakatani, Shogo ; Isobe, Yoshiaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines</topic><topic>Analytical, structural and metabolic biochemistry</topic><topic>Biological and medical sciences</topic><topic>Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists & inhibitors</topic><topic>Calmodulin-dependent protein kinase II</topic><topic>Enzymes and enzyme inhibitors</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Inhibitors</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Pyrimidines - pharmacology</topic><topic>Transferases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Asano, Shigehiro</creatorcontrib><creatorcontrib>Komiya, Masafumi</creatorcontrib><creatorcontrib>Koike, Nobuyuki</creatorcontrib><creatorcontrib>Koga, Erina</creatorcontrib><creatorcontrib>Nakatani, Shogo</creatorcontrib><creatorcontrib>Isobe, Yoshiaki</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Asano, Shigehiro</au><au>Komiya, Masafumi</au><au>Koike, Nobuyuki</au><au>Koga, Erina</au><au>Nakatani, Shogo</au><au>Isobe, Yoshiaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-11-15</date><risdate>2010</risdate><volume>20</volume><issue>22</issue><spage>6696</spage><epage>6698</epage><pages>6696-6698</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>A novel series of 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidines containing substituted phenyl sulfonamide are synthesized and evaluated for their inhibitory activity against CaMKII. Substituents on the phenyl group had significant impact on CaMKII inhibition, in particular, the inhibitory activity of 8p was 25-fold higher than that of KN-93, a known CaMKII inhibitor. Michaelis–Menten analysis of a representative compound suggested that the synthesized pyrimidines are calmodulin non-competitive inhibitors. Finally, 8p exhibited more than 100-fold higher selectivity for CaMKII over five types of off-target kinases.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20875738</pmid><doi>10.1016/j.bmcl.2010.09.005</doi><tpages>3</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6696-6698 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_867749891 |
source | ScienceDirect Journals |
subjects | 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines Analytical, structural and metabolic biochemistry Biological and medical sciences Calcium-Calmodulin-Dependent Protein Kinase Type 2 - antagonists & inhibitors Calmodulin-dependent protein kinase II Enzymes and enzyme inhibitors Fundamental and applied biological sciences. Psychology Inhibitors Medical sciences Miscellaneous Pharmacology. Drug treatments Protein Kinase Inhibitors - pharmacology Pyrimidines - pharmacology Transferases |
title | 5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidines as novel class of potent and highly selective CaMKII inhibitors |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T23%3A58%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=5,6,7,8-Tetrahydropyrido%5B4,3-d%5Dpyrimidines%20as%20novel%20class%20of%20potent%20and%20highly%20selective%20CaMKII%20inhibitors&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Asano,%20Shigehiro&rft.date=2010-11-15&rft.volume=20&rft.issue=22&rft.spage=6696&rft.epage=6698&rft.pages=6696-6698&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.09.005&rft_dat=%3Cproquest_cross%3E759323660%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c417t-75b0126b751aa95ea1b667c236a87d07e144cc415f29658a3b651d0d8ac6c6393%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=759323660&rft_id=info:pmid/20875738&rfr_iscdi=true |